Background: Hepatitis C virus (HCV) is a major cause of non-A non-B he
patitis. Detection of circulating antibodies against HCV by enzyme-lin
ked immunosorbent assay (ELISA) has provided the main approach for the
diagnosis of HCV infection. Most ELISA kits use a mixture of core, NS
3, NS4 and NS5 antigen as capture antigens and enzyme-labeled goat ant
i-human Ige as conjugate. Objectives: To establish an ELISA system bas
ed on the antigen-capturing principle, using a recombinant chimeric po
lyprotein containing four HCV antigenic components as antigen. Study d
esign: HCV antigens were expressed in Escherichia coli as chimeric pol
yprotein either in inclusion bodies or in soluble form. Protein expres
sed in inclusion bodies was used as solid-phase antigen, and the antig
en expressed in a soluble form was used as enzyme conjugate after bein
g labeled with horseradish peroxidase (HRP). Results: Genes coding HCV
antigens were cloned and sequenced, chimeric polyproteins containing
four immunodominant components (core, NS3, NS4 and NS5) were expressed
in E. coli both in soluble and in inclusion body form. These two chim
eric proteins retained the antigenicity of HCV antigens. Antibody-capt
uring ELISA using the chimeric antigens showed a sensitivity of 97% (9
7/100) and a specificity of 98% (97/99) using the reference panel from
the National Institute for the Control of Pharmaceutic and Biological
Products of China (NICPBC); the same assay showed a sensitivity of 97
.9% (48/49) and a specificity of 100% (43/43) using the self-establish
ed reference panel. Antigen-capturing ELISA was set up using the antig
en labeled with horseradish peroxidase as conjugate, and was shown to
be as sensitive as (97.9%) and more specific than (100%) antibody-capt
uring ELISA using the reference panel in this work. The antigen-captur
ing ELISA also showed a high accordance (98.9%) with UBI HCV enzyme im
munoassay (EIA) 4.0 kits (United Biomedical Inc. USA). Conclusion: Ant
igen-capturing ELISA provided a convenient, sensitive and more specifi
c approach for the diagnosis of hepatitis C virus infection.